Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Etomidate

An intravenous hypnotic used to induce general anaesthesia, developed in 1964 and introduced in Europe in 1972: it is valued because it causes only a small drop in blood pressure. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards, nitrosamines and other impurities.

Did you know?The molecule exists in two mirror-image forms, but only the R form is used clinically: it is about ten times more potent than the other.

EtomidateGo to the active ingredient →
EtomidateActive ingredientEtomidateCat. No. P-E136-001CAS 33125-97-2
Etomidate-d5Isotopically labelledEtomidate-d5Cat. No. P-E136-008CAS 3046414-03-0

EDQM standards 2

The official European Pharmacopoeia standards for this family.

Reference substanceEtomidate CRSEDQM code E2503000Family Etomidate

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.